Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
203M
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
40.3M
-
Shares change
-
+102K
-
Total reported value, excl. options
-
$646M
-
Value change
-
-$273M
-
Put/Call ratio
-
0.41
-
Number of buys
-
77
-
Number of sells
-
-86
-
Price
-
$16.04
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q1 2021
186 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q1 2021.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.3M shares
of 203M outstanding shares and own 19.85% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (6.36M shares), VANGUARD GROUP INC (4M shares), BlackRock Inc. (3.69M shares), STATE STREET CORP (3.62M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.47M shares), BVF INC/IL (1.14M shares), Alpine Global Management, LLC (1.1M shares), GOLDMAN SACHS GROUP INC (1.05M shares), BOXER CAPITAL, LLC (1M shares), and Woodline Partners LP (897K shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.